The Globe and Mail interviewed Michael Law, a professor at UBC’s school of population and public health and Canada Research Chair in Access to Medicines, about new pharmaceuticals for rare diseases.
Law said private insurers and governments can negotiate discounts from the list price of pharmaceuticals.
